Duality Biotherapeutics, Inc.

Duality Biotherapeutics, Inc.

HHKEX:9606
93.25
HKD
-4.05
(-4.16%)
16.41BMarket Cap
Mar 23Next Earn

Total Valuation

HKD

As of June 30, 2026, Duality Biotherapeutics, Inc. carries a market capitalization of 16.41B, placing it among publicly traded companies globally. Its enterprise value stands at 13.34B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap16.41B
Enterprise Value13.34B

Important Dates

Duality Biotherapeutics, Inc.'s next confirmed earnings release is scheduled for March 23, 2027.

Earnings Date3/23/2027

Share Statistics

As of June 30, 2026, Duality Biotherapeutics, Inc. has 90.54M shares outstanding.

Shares Outstanding90.54M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio9.79
P/TBV Ratio9.81

Financial Position

As of June 30, 2026, Duality Biotherapeutics, Inc. maintains a current ratio of 1.99, meaning it holds 2.0x the short-term assets needed to cover near-term liabilities.

Current Ratio1.99
Quick Ratio1.74
Debt / Equity26.16

Financial Efficiency

These figures cover the twelve months ended June 30, 2026.

Employee Count231.00

Stock Price Statistics

HKD

As of the close on November 17, 2026, Duality Biotherapeutics, Inc.'s stock has declined approximately 72.83% over the past 52 weeks. The 50-day moving average sits at 158.22, while the 200-day moving average is 226.03.

52-Week Price Change-72.83%
50-Day Moving Average158.22
200-Day Moving Average226.03

Balance Sheet

HKD

As of June 30, 2026, Duality Biotherapeutics, Inc. holds 3.51B in cash and equivalents against 438.57M in total debt, resulting in a net debt position of -2.19B. Total book value stands at 1.68B, with working capital of 1.99B providing operational flexibility.

Cash & Cash Equivalents3.51B
Total Debt438.57M
Net Debt-2.19B
Equity (Book Value)1.68B
Book Value Per Share18.52
Working Capital1.99B